Neoral conversion in stable thoracic transplant patients leads to dose reduction.
Zaldonis
D B
DB
Division of Cardiothoracic Surgery, University of Pittsburgh Medical Center, PA 15213, USA.
Keenan
R J
RJ
Pham
S M
SM
Kormos
R L
RL
Griffith
B P
BP
D000284:Administration, Oral; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D016040:Lung Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine